Choosing initial MS therapy; personal, disease, and medication factors
Initiating disease modifying therapy in a patient with newly diagnosed relapsing multiple sclerosis currently offers the best opportunity to influence their subsequent disease course. This article reviews personal factors, disease presentation characteristics, and data on current disease modifying t...
Saved in:
| Main Author: | Bruce A. Cohen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Neurotherapeutics |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1878747925000601 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adherence to disease modifying therapies in patients with multiple sclerosis
by: D. Pileckė, et al.
Published: (2019-06-01) -
Patient Experiences with the Impacts of Multiple Sclerosis & Disease-Modifying Therapies
by: Talente, et al.
Published: (2025-03-01) -
Ageing and multiple sclerosis
by: Julija Isačenko, et al.
Published: (2024-12-01) -
Multiple sclerosis and pregnancy. Impact of multiple sclerosis disease-modifying therapy on the health of newborns
by: T. I. Yakushina
Published: (2021-02-01) -
Pediatric multiple sclerosis: Improving outcome through high-efficacy therapies
by: Lama Saleh Aljomah, et al.
Published: (2025-07-01)